Skip to main content
Equibles

Steven Ledger

CEO

Serina Therapeutics, Inc. (SER)

Board Member

Serina Therapeutics, Inc. (SER)

Equibles does not estimate personal net worth.

Get an email with a short summary when Serina Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get SER alerts

About Steven Ledger

Steven Ledger is recorded as CEO at Serina Therapeutics, Inc. (SER) since September 8, 2024 and Board Member at Serina Therapeutics, Inc. (SER) since March 26, 2024. Serina Therapeutics, Inc. reported in an 8-K filed September 12, 2024 that Steven Ledger was appointed Chief Executive Officer, effective September 8, 2024. Serina Therapeutics, Inc. reported in an 8-K filed April 1, 2024 that Steven Ledger was appointed Class II Director, effective March 26, 2024. Serina Therapeutics, Inc. reported in an 8-K filed April 1, 2024 that Steven Ledger was appointed Interim Chief Executive Officer, effective March 26, 2024. Serina Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Serina Therapeutics, Inc. includes Joanne M. Hackett (CEO), Steve Ledger (CEO), Gregory H. Bailey (Chairman and Board Member) and 7 others.

“On September 8, 2024, the Board of Directors (the “Board”) of Serina Therapeutics, Inc. (the “Company”) appointed Steven Ledger, the current Interim Chief Executive Officer of the Company, to be the Company’s Chief Executive Officer.”
Serina Therapeutics, Inc. Form 8-K, filed September 12, 2024 · Read the filing
“Steven Ledger and Dr. J. Milton Harris appointed as Class II directors of the Company whose terms expire at the 2025 annual meeting of stockholders”
Serina Therapeutics, Inc. Form 8-K, filed April 1, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Serina Therapeutics, Inc.

Recent activity